Background: Pevonedistat (P), the first small-molecule inhibitor of the neural precursor cell expressed, developmentally downregulated 8 (NEDD 8)-activating enzyme, disrupts proteasom-al degradation of select proteins and has shown promising clinical activity and good tolerability in combination with azacitidine (A) in acute myeloid leukemia (AML).
展开▼
